
Brandon Blue, MD
@drbluemd
ID: 895006151946911744
08-08-2017 19:37:49
111 Tweet
409 Followers
258 Following


Hear the latest in multiple myeloma care from the experts, Brandon Blue, M.D. (Brandon Blue, MD) of Moffitt Cancer Center on June 8 at CURE®’s Educated Patient® Multiple Myeloma Summit. Learn more and register today! globalmeet.webcasts.com/starthere.jsp?… #educatedpatient #multiplemyeloma CURE Today


Improving access to the 4 Ts—triplets, transplants, clinical trials, and CAR T—for Black patients with multiple myeloma: Join the conversation in new CME activity. Brandon Blue, MD #PeerVoice #meded #MM #myeloma #multiplemyeloma #oncology peervoice.com/NEQ?PromoCode=…


When a person receives a diagnosis of #MultipleMyeloma, the questions are endless. So, we spoke with Brandon Blue, MD of Moffitt Cancer Center about frequently asked questions related to multiple myeloma. curetoday.com/view/multiple-…


In a day and age with advanced treatments for #MultipleMyeloma, there are so many questions to be answered. CURE® had a Q&A session with Brandon Blue, MD of Moffitt Cancer Center to discuss treatments and side effects associated with multiple myeloma. curetoday.com/view/10-multip…




Starting our FLASCO #Cancer Equity and Disparities conference with great speakers Drs Robert Winn, Folake Odedina Mayo Clinic VCU Blase Polite Sybil Green ASCO Alyssa Schatz National Comprehensive Cancer Network (NCCN) John Careters Brandon Blue Moffitt Cancer Center Eduardo Sotomayor Tampa General Hospital @manalipatelmd



At #ASH24, Brandon Blue, MD (Brandon Blue, MD) joined Jeff Lancet, MD (Jeff Lancet) to discuss racial outcome disparities and the latest advancements in multiple myeloma. #MoffittASH24 ASH

At #ASH24, Brandon Blue, MD (Brandon Blue, MD) joined Jeff Lancet, MD (Jeff Lancet) to discuss racial outcome disparities and the latest advancements in multiple myeloma. #MoffittASH24 ASH

Congratulations to Brandon Blue, MD (Brandon Blue, MD), who was recognized for his groundbreaking work in cancer research and his advocacy for equitable healthcare at the KBLA Talk Gala! Learn more ➡️ bit.ly/4bzpEoN #MoffittCancerCenter #CancerResearch


Brandon Blue, MD at #ASCO25: Trispecifics could be a game-changer in #MultipleMyeloma. “The more targets you hit on the plasma cell, the better cancer killing you get.” bit.ly/4mKdm1O #Hematology #MMSM #CarTCellTherapy

Happening now at #ASCO25: Moffitt’s Brandon Blue, MD, (Brandon Blue, MD) chairs the Oral Abstract Session on Hematologic Malignancies—Plasma Cell Dyscrasia. Experts explore new research, clinical impact and future directions in plasma cell disorders. Tune in now:


#ASCO25 #myeloma Aurore Perrot C. Ola Landgren, M.D. Suzanne Lentzsch, MD, PhD Brandon Blue, MD Francesca Gay and Philippe Moreau. The rode to cure? MRD seems to matter. Longer follow up needed. Great studies presented at the oral session.




Brandon Blue, MD at #ASCO25: Trispecifics could be a game-changer in #MultipleMyeloma. “The more targets you hit on the plasma cell, the better cancer killing you get.” bit.ly/4mKdm1O #Hematology #MMSM #CarTCellTherapy

In this episode of How This Is Building Me, D. Ross Camidge of CU Cancer Center and Brandon Blue, MD of Moffitt Cancer Center discuss Dr Blue’s journey to practicing medicine & how he settled on treating malignant hematologic conditions. Listen now 🎧: onclive.com/view/how-passi… #hematology #oncology
